Logo image of CTRI

CENTURI HOLDINGS INC (CTRI) Stock Fundamental Analysis

NYSE:CTRI - New York Stock Exchange, Inc. - US1559231055 - Common Stock - Currency: USD

22.14  -0.32 (-1.42%)

After market: 22.14 0 (0%)

Fundamental Rating

3

Taking everything into account, CTRI scores 3 out of 10 in our fundamental rating. CTRI was compared to 52 industry peers in the Construction & Engineering industry. The financial health of CTRI is average, but there are quite some concerns on its profitability. CTRI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CTRI had positive earnings in the past year.
CTRI had a positive operating cash flow in the past year.
CTRI Yearly Net Income VS EBIT VS OCF VS FCFCTRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CTRI has a Return On Assets of 0.02%. This is in the lower half of the industry: CTRI underperforms 67.31% of its industry peers.
CTRI has a worse Return On Equity (0.07%) than 67.31% of its industry peers.
CTRI has a Return On Invested Capital (4.59%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CTRI is significantly below the industry average of 16.60%.
The last Return On Invested Capital (4.59%) for CTRI is above the 3 year average (4.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.02%
ROE 0.07%
ROIC 4.59%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
CTRI Yearly ROA, ROE, ROICCTRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

CTRI has a Profit Margin of 0.01%. This is in the lower half of the industry: CTRI underperforms 61.54% of its industry peers.
CTRI has a Operating Margin (3.61%) which is in line with its industry peers.
CTRI's Operating Margin has declined in the last couple of years.
The Gross Margin of CTRI (8.56%) is worse than 69.23% of its industry peers.
CTRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.61%
PM (TTM) 0.01%
GM 8.56%
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
CTRI Yearly Profit, Operating, Gross MarginsCTRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5

4

2. Health

2.1 Basic Checks

CTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CTRI has more shares outstanding than it did 1 year ago.
The debt/assets ratio for CTRI has been reduced compared to a year ago.
CTRI Yearly Shares OutstandingCTRI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
CTRI Yearly Total Debt VS Total AssetsCTRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.30 indicates that CTRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRI has a Altman-Z score of 2.30. This is comparable to the rest of the industry: CTRI outperforms 48.08% of its industry peers.
The Debt to FCF ratio of CTRI is 8.40, which is on the high side as it means it would take CTRI, 8.40 years of fcf income to pay off all of its debts.
CTRI's Debt to FCF ratio of 8.40 is in line compared to the rest of the industry. CTRI outperforms 53.85% of its industry peers.
A Debt/Equity ratio of 1.56 is on the high side and indicates that CTRI has dependencies on debt financing.
The Debt to Equity ratio of CTRI (1.56) is worse than 71.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 8.4
Altman-Z 2.3
ROIC/WACC0.45
WACC10.26%
CTRI Yearly LT Debt VS Equity VS FCFCTRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.57 indicates that CTRI should not have too much problems paying its short term obligations.
CTRI has a better Current ratio (1.57) than 76.92% of its industry peers.
CTRI has a Quick Ratio of 1.57. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a better Quick ratio (1.57) than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
CTRI Yearly Current Assets VS Current LiabilitesCTRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

CTRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.24%, which is quite impressive.
The Revenue has decreased by -9.04% in the past year.
The Revenue has been growing slightly by 6.90% on average over the past years.
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.94%
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%4.18%

3.2 Future

Based on estimates for the next years, CTRI will show a very strong growth in Earnings Per Share. The EPS will grow by 62.73% on average per year.
CTRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.84% yearly.
EPS Next Y127.79%
EPS Next 2Y77.96%
EPS Next 3Y62.73%
EPS Next 5YN/A
Revenue Next Year5.55%
Revenue Next 2Y5.48%
Revenue Next 3Y5.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTRI Yearly Revenue VS EstimatesCTRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CTRI Yearly EPS VS EstimatesCTRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 63.26 indicates a quite expensive valuation of CTRI.
The rest of the industry has a similar Price/Earnings ratio as CTRI.
Compared to an average S&P500 Price/Earnings ratio of 26.92, CTRI is valued quite expensively.
With a Price/Forward Earnings ratio of 24.11, CTRI is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTRI is on the same level as its industry peers.
CTRI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 63.26
Fwd PE 24.11
CTRI Price Earnings VS Forward Price EarningsCTRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRI is valued cheaper than 82.69% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CTRI is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.89
EV/EBITDA 12.2
CTRI Per share dataCTRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CTRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRI's earnings are expected to grow with 62.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y77.96%
EPS Next 3Y62.73%

0

5. Dividend

5.1 Amount

CTRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURI HOLDINGS INC

NYSE:CTRI (6/27/2025, 8:04:01 PM)

After market: 22.14 0 (0%)

22.14

-0.32 (-1.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)07-28 2025-07-28
Inst Owners28.84%
Inst Owner Change4.28%
Ins Owners0.35%
Ins Owner Change-51.18%
Market Cap1.96B
Analysts75.38
Price Target22.54 (1.81%)
Short Float %7.97%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.86%
Min EPS beat(2)-4.24%
Max EPS beat(2)19.97%
EPS beat(4)1
Avg EPS beat(4)-19.24%
Min EPS beat(4)-80.47%
Max EPS beat(4)19.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)4.44%
Revenue beat(4)1
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-13.35%
Max Revenue beat(4)4.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.74%
PT rev (3m)-3.49%
EPS NQ rev (1m)6.34%
EPS NQ rev (3m)4.98%
EPS NY rev (1m)5.36%
EPS NY rev (3m)-4.37%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)3.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 63.26
Fwd PE 24.11
P/S 0.74
P/FCF 18.89
P/OCF 9.96
P/B 3.66
P/tB N/A
EV/EBITDA 12.2
EPS(TTM)0.35
EY1.58%
EPS(NY)0.92
Fwd EY4.15%
FCF(TTM)1.17
FCFY5.29%
OCF(TTM)2.22
OCFY10.04%
SpS30
BVpS6.05
TBVpS-1.87
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.07%
ROCE 5.81%
ROIC 4.59%
ROICexc 4.63%
ROICexgc 8.12%
OM 3.61%
PM (TTM) 0.01%
GM 8.56%
FCFM 3.91%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
ROICexc(3y)4.47%
ROICexc(5y)N/A
ROICexgc(3y)8.1%
ROICexgc(5y)N/A
ROCE(3y)5.52%
ROCE(5y)N/A
ROICexcg growth 3Y-0.39%
ROICexcg growth 5YN/A
ROICexc growth 3Y9.2%
ROICexc growth 5YN/A
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
F-Score6
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 8.4
Debt/EBITDA 3.61
Cap/Depr 68.91%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 85.24%
Profit Quality 26177.1%
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 2.3
F-Score6
WACC10.26%
ROIC/WACC0.45
Cap/Depr(3y)76.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.94%
EPS Next Y127.79%
EPS Next 2Y77.96%
EPS Next 3Y62.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%4.18%
Revenue Next Year5.55%
Revenue Next 2Y5.48%
Revenue Next 3Y5.84%
Revenue Next 5YN/A
EBIT growth 1Y-36.39%
EBIT growth 3Y0.48%
EBIT growth 5YN/A
EBIT Next Year149.17%
EBIT Next 3Y46.31%
EBIT Next 5YN/A
FCF growth 1Y-3.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.51%
OCF growth 3Y13.06%
OCF growth 5YN/A